Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Therma Bright Provides Update on Orpheus Medica Rapid Test for COVID-19 Virus in Saliva – CoviSafe(TM)
Generex Biotechnology Corporation
-
July 16, 2020
0
Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
Generex Biotechnology Corporation
-
June 17, 2020
0
Therma Bright Provides Corporate Update on the Saringer and Orpheus Transactions
Generex Biotechnology Corporation
-
August 20, 2020
0
Biotech News
Home
Biotech News
Biotech News
Generex Announces Signed Agreement with Bintai Kinden to Advance the Clinical...
Generex Biotechnology Corporation
-
August 18, 2020
0
Biotech News
BetterLife Announces Closing of Private Placement
BetterLife Pharma Inc.
-
August 19, 2020
0
Biotech News
Generex Biotechnology Files Pre-IND Briefing Package with FDA for Ii-Key-SARS-CoV-2 Peptide...
Generex Biotechnology Corporation
-
July 20, 2020
0
Biotech News
Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine...
Moderna Inc.
-
July 8, 2020
0
1
2
3
...
22
Page 1 of 22
- Advertisement -
APPLE
BioSig Technologies (BSGM) PT Raised to $12.50 at Chardan Ahead of...
Moderna Inc.
-
September 20, 2018
0
Biotech News
Chardan Capital Markets analyst Keay Nakae raised the price target on BioSig Technologies (OTC: BSGM) to $12.50 (from $5.00) while maintaining a Buy rating ahead of...
RECENT POSTS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Moderna Inc.
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Moderna Inc.
-
February 22, 2021
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Moderna Inc.
-
January 19, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Moderna Inc.
-
December 22, 2020
